tiprankstipranks

John S Yu Insider Profile

4 Followers
John S Yu, Director at ImmunoCellular Therapeutics, holds 5.34M shares in Kairos Pharma, Ltd. (Ticker: KAPA), holds 120.51K shares in ImmunoCellular Therapeutics (Ticker: IMUC). Most recently, John S Yu Bought ― shares of Kairos Pharma, Ltd. on Nov 21, 2024 for an estimated value of 5.76K.
tipranks
John S Yu

John S Yu
ImmunoCellular Therapeutics (IMUC)
Director

Ranked #78,923 out of 99,635 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-24.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$9M
99.76%
0.24%
A breakdown of John S Yu's holdings

Insider Roles

Kairos Pharma, Ltd.
(KAPA)
CEO and Chairman, Director, Ten Percent Owner
ImmunoCellular Therapeutics
(IMUC)
Director
Roles that John S Yu holds in companies

Most Profitable Insider Trade

Stock:
Kairos Pharma, Ltd.
(KAPA)
Rating:Informative Buy
Date:Nov 21, 2024 - Today
Return:+6.60%
The most profitable trade made by John S Yu

John S Yu's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ImmunoCellular Therapeutics
Jun 08, 2018
Director
Uninformative Buy
$20.49K
Kairos Pharma, Ltd.
Nov 21, 2024
CEO and Chairman, Director, Ten Percent Owner
Informative Buy
5.76K
$8.55M
List of latest transactions for each holding click on a transaction to see John S Yu's performance on stock

John S Yu insider profile FAQ

What is the percentage of profitable transactions made by John S Yu?
The percentage of profitable transactions made by John S Yu is 25%.
    What is the average return per transaction made by John S Yu?
    The average return per transaction made by John S Yu is -24.10%.
      What stocks does John S Yu hold?
      John S Yu holds: IMUC, KAPA stocks.
        What was John S Yu’s latest transaction?
        John S Yu latest transaction was an Informative Buy of $5.76K.
          What was John S Yu's most profitable transaction?
          John S Yu’s most profitable transaction was an Informative Buy of KAPA stock on November 21, 2024. The return on the trade was 6.60%.
            What is John S Yu's role in ImmunoCellular Therapeutics?
            John S Yu's role in ImmunoCellular Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.